COLUMBIA, Md., March 13, 2007 /PRNewswire-FirstCall via COMTEX News Network/ --
DHA omega-3 innovator Martek Biosciences Corporation (Nasdaq: MATK) announced today that Parmalat Australia Ltd. has launched Vaalia My First Yoghurt with life'sDHA(TM). Now available in major supermarket chains throughout Australia, Vaalia My First Yoghurt features 36 mg of life'sDHA(TM) per 60 g serving for infant brain and eye health.
Parmalat Australia is a wholly owned subsidiary of Parmalat SpA, an Italian-based global dairy company with major operations in Europe, Latin America, North America and Australia. Its worldwide operations include almost 140 production centers and more than 36,000 employees.
In Australia, Martek is represented by distributor VILCO PTY LTD, Australia, to make the use of life'sDHA(TM) in food and beverages a commercial success.
"Vaalia My First Yoghurt with life'sDHA(TM) demonstrates the growing global awareness of the health benefits of DHA for infants and children," said Steve Dubin, CEO of Martek Biosciences. "Martek is pleased to be working with Parmalat Australia Ltd., one of the largest dairy manufacturers in Australia."
DHA omega-3 is a long-chain omega-3 fatty acid that serves as a primary building block for the brain and the eyes and supports brain, eye and cardiovascular health throughout life. There is a large and growing body of scientific evidence demonstrating that people of all ages, from infants to aging adults, benefit from an adequate supply of DHA omega-3 in their diets. Scientific reviews have noted the importance of DHA omega-3 in proper brain and eye function, and there are studies currently underway to investigate its role in decreasing the prevalence of certain neurological disorders.
Martek's life'sDHA(TM) is unique in the market because it is derived from a sustainable and vegetarian source. Made from microalgae under tightly controlled manufacturing conditions, life'sDHA(TM) is free of oceanic contaminants that may be present in certain fish or fish oils. Microalgae are the only vegetarian source of DHA omega-3, the key omega-3 for brain development and function.
Parmalat Australia Ltd. (previously Pauls Limited) specializes in the production of branded milk and dairy products and is one of the major manufacturers of milk, yoghurt and fresh dairy products in Australia. The company has an impressive stable of well recognized, popular milk and dairy product brands which are sold in both Australia and overseas, including Parmalat, Pauls, Trim, PhysiCAL, Breaka, Ice Break and Vaalia.
Martek Biosciences Corporation (Nasdaq: MATK) is a leader in the innovation and development of DHA omega-3 products that promote health and wellness through every stage of life. The Company produces life'sDHA(TM), a vegetarian source of the omega-3 fatty acid DHA (docosahexaenoic acid), for use in foods, beverages, infant formula, and supplements, and ARA (arachidonic acid), an omega-6 fatty acid, for use in infant formula. For more information on Martek Biosciences, visit http://www.martek.com.
Sections of this release contain forward-looking statements concerning, among other things, expectations regarding Parmalat Australia's Vaalia My First Yoghurt with life'sDHA(TM) product launch, customer acceptance of life'sDHA(TM), and widespread use of life'sDHA(TM). These statements are based upon numerous assumptions which Martek cannot control and involve risks and uncertainties that could cause actual results to differ. These statements should be understood in light of the risk factors set forth in the Company's filings with the Securities and Exchange Commission, including, but not limited to, the Company's Form 10-K for the fiscal year ended October 31, 2006 and other filed reports on Form 10-K, Form 10-K/A, Form 10-Q and Form 8-K.